Watchung, NJ, United States of America

Ruo Xu

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2005-2020

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Ruo Xu: Pioneering Innovations in Medicinal Chemistry

Introduction:

Inventor Ruo Xu, hailing from Watchung, NJ (US), is a trailblazer in the field of medicinal chemistry. Passionate about innovation and committed to excellence, his work continues to inspire the next generation of inventors.

Latest Patents:

Ruo Xu's latest patents showcase his groundbreaking work in the medicinal chemistry domain:

1. Imidazo-pyrimidone Compounds: Ruo Xu's patented compounds stimulate the body to produce tumor necrosis factor-related apoptosis-inducing ligands, offering novel treatment options for related tumors.

2. Gamma Secretase Modulators: His invention introduces a novel class of compounds as modulators of gamma secretase, with applications in treating diseases associated with the central nervous system.

Career Highlights:

Having accumulated an impressive 13 patents, Ruo Xu has made significant contributions to the field. He has lent his expertise to renowned companies such as Schering Corporation and Merck Sharp & Dohme Corporation, where he has played a pivotal role in shaping the landscape of medicinal chemistry.

Collaborations:

Throughout his career, Ruo Xu has collaborated with esteemed professionals in the industry. Noteworthy coworkers include John W Clader and Hubert B Josien, with whom he has worked closely to drive innovation and propel advancements in medicinal chemistry.

Conclusion:

Ruo Xu's dedication to pushing the boundaries of what is possible in medicinal chemistry serves as a testament to the transformative power of creativity and ingenuity. His relentless pursuit of excellence continues to pave the way for future breakthroughs in the field, leaving an indelible mark on the world of inventions and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…